RIPK3 and cancer: Moreover, RIPK3, highly expressed in mouse models of CRC and in a subset of human CRC cell lines, seems to be the deciding factor of cancer cell susceptibility, second to mitochondria-derived activator of caspase (SMAC) mimetic-induced necroptosis [154].